# BWXT Medical Ltd. – FDA Inspection, Mar 3, 2023

Source: https://www.keypedia.com/records/fda_inspections/bwxt-medical-ltd/4b68b591-130a-4cec-a413-6af58ef5c04f
Source feed: FDA_Inspections

> FDA inspection 1199111 of BWXT Medical Ltd., March 03, 2023. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199111
- Company Name: BWXT Medical Ltd.
- Inspection Date: 2023-03-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- FDA Inspection 1203603 - 2023-03-02
- FDA Inspection 1098832 - 2019-06-07
- [FDA Inspection 1000973 - 2016-12-06](https://www.keypedia.com/records/fda_inspections/bwxt-medical-ltd/1d90570b-38ed-4a6a-a82a-ca205b940401)
- FDA Inspection 903686 - 2014-11-07
- FDA Inspection 777619 - 2012-04-04

## Related Officers

- [Michele Gottshall](https://www.keypedia.com/people/michele-gottshall/f12dcaf7-8958-4591-88bb-f9746796b934)
- [FDA Associated Person](https://www.keypedia.com/people/truong-x-nguyen/8f3aed17-0507-4272-a3b8-9188d761faed)

Company: https://www.keypedia.com/companies/bwxt-medical-ltd/daca3574-a5c6-4ea6-9c97-48d79c797a5d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
